# Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers

> **NCT02386917** · NA · ACTIVE_NOT_RECRUITING · sponsor: **The Hospital of Vestfold** · enrollment: 100 (estimated)

## Conditions studied

- Obesity

## Interventions

- **PROCEDURE:** Gastric bypass
- **BEHAVIORAL:** Very low calorie diet

## Key facts

- **NCT ID:** NCT02386917
- **Lead sponsor:** The Hospital of Vestfold
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-03-18
- **Primary completion:** 2019-06
- **Final completion:** 2028-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02386917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02386917, "Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02386917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*